Prostate Cancer - Results from #26580

Mathematical modeling of prostate cancer progression in response to androgen ablation therapy - Abstract January 5, 2012

Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population - Abstract January 5, 2012

Prediction of prostate cancer risk: The role of prostate volume and digital rectal examination in the ERSPC risk calculators - Abstract January 5, 2012

Acoustic radiation force impulse imaging of human prostates: Initial in vivo demonstration - Abstract January 5, 2012

Pathological outcomes of men eligible for active surveillance after undergoing radical prostatectomy: Are results predictable? - Abstract January 5, 2012

Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients - Abstract January 5, 2012

The results of transperineal versus transrectal prostate biopsy: A systematic review and meta-analysis - Abstract January 4, 2012

Oral contraceptive use is associated with prostate cancer: An ecological study - Abstract January 4, 2012

Urinary proteome analysis for prostate cancer diagnosis: Cost-effective application in routine clinical practice in Germany - Abstract January 4, 2012

Combined histoarchitectural and cytological biopsy grading improves grading accuracy in low-grade prostate cancer - Abstract January 4, 2012

Population screening for prostate cancer: An overview of available studies and meta-analysis - Abstract January 4, 2012

Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer - Abstract January 3, 2012

The Exercising Together project: Design and recruitment for a randomized, controlled trial to determine the benefits of partnered strength training for couples coping with prostate cancer - Abstract January 3, 2012

ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer - Abstract January 3, 2012

Predicting prostate cancer many years before diagnosis: How and why? - Abstract January 3, 2012

Novel options for the treatment of castration-resistant prostate cancer - Abstract January 3, 2012

Comparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response - Abstract January 3, 2012

Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer - Abstract December 23, 2011

Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer - Abstract December 23, 2011

Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration - Abstract December 23, 2011

Page 1330 of 1436